Loss of p16 INK4 expression in invasive squamous cell carcinoma of the uterine cervix is an adverse prognostic marker [3]

Histopathology

Volumn 49, Issue 5, 2006, Pages 542-545

  Masoudi, H ^a   Van Niekerk, D J ^a   Gilks, C B ^a   Cheang, M ^a   Bilek, K ^b   Fischer, U ^b   Ehlen, T ^a   Miller, D ^a   Horn, L C ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN P16INK4A;

CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CELL PROLIFERATION; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LETTER; MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; UTERINE CERVIX;

CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PROGNOSIS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 33750309495     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2006.02510.x     Document Type: Letter

References (12)

1. Keating JT, Cviko A, Riethdorf S et al. Ki-67, cyclin E, and p16INK4 are complementary surrogate biomarkers for human papillomavirus-related cervical neoplasia. Am. J. Surg. Pathol. 2001; 25; 884-891.
2. Milde-Langosch K, Riethdorf S, Kraus-Pöppinghaus A et al. Expression of cyclin-dependent kinase inhibitors p16MTS1, 21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas. Virchows Arch. 2001; 439; 55-61.
3. Sevin BU, Nadji M, Lampe B et al. Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer 1995; 76; 1978-1986.
4. Kawabuchi B, Moriyama S, Hironaka M et al. p16 inactivation in small-sized lung adenocarcinoma: its association with poor prognosis. Int. J. Cancer 1999; 84; 49-53.
5. Nakashima R, Fujita M, Enomoto T et al. Alteration of p16 and p15 genes in human uterine tumours. Br. J. Cancer 1999; 80; 458-467.
6. Hirama T, Miller CW, Wilczynski SP et al. p16 (CDKN2/cyclin-dependent kinase-4 inhibitor/multiple tumor suppressor-1) gene is not altered in uterine cervical carcinomas or cell lines. Mod. Pathol. 1996; 9; 26-31.
7. Van de Putte G, Holm R, Lie AK et al. Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis. Gynecol. Oncol. 2003; 89; 140-147.
8. Amortegui AJ, Meyer MP, Elborne VL et al. P53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus DNA-positive cervical intraepithelial neoplasia and invasive cancer. Mod. Pathol. 1995; 8; 907-912.
9. Dürst M, Glitz D, Schneider A et al. Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 1992; 189; 132-140.
10. Dyson N, Howley PM, Munger K et al. The human papillomavirus-16, E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243; 934-937.
11. Xiong Y, Kuppuswarny D, Li Y et al. Alteration of cell cycle kinase complexes in human papillomavirus 16, E6- and E7-expressing fibroblasts precedes neoplastic transformation. J. Virol. 1996; 70; 999-1008.
12. Van de Putte G, Kristensen GB, Lie AK et al. Cyclins and proliferation markers in early squamous cervical carcinoma. Gynecol. Oncol. 2004; 92; 40-46.